Lynn Kelvin L, McGregor David O, Moesbergen Todd, Buttimore Adrian L, Inkster Judith A, Wells J Elisabeth
Department of Nephrology, Christchurch Hospital, Christchurch, New Zealand.
Kidney Int. 2002 Dec;62(6):2281-7. doi: 10.1046/j.1523-1755.2002.00685.x.
Previous studies of the risks of hypertension for dialysis patients have yielded conflicting results. The aim of this study was to investigate, in a home dialysis population with low rates of diabetes and antihypertensive drug use, whether blood pressure (BP) was an independent risk factor for survival.
The outcome of 168 consecutive patients (94 male, 88% Caucasian), aged 48 years (SD 16), who began home hemodialysis (HD; N = 124) or home continuous ambulatory peritoneal dialysis (CAPD; N = 44) between January 1, 1985 and December 31, 1994 were analyzed retrospectively. Only 4.7% of patients took antihypertensive drugs while on dialysis. The patients were followed to December 31, 1998 with the primary outcome being all-cause mortality. Censoring events were transplantation, transfer to another center and treatment modality change. The Cox proportional hazard model was used with baseline predictors.
Seventy-one patients died and the median overall survival was 4.2 years (5.6 on HD, 2.2 on CAPD, P < 0.0001). Mean BP at start of dialysis predicted survival on its own (P = 0.0009) and in the joint Cox model (P = 0.047). Other significant predictors in the joint model were age [10 year increase, relative hazard (RH) = 1.55, P = 0.0008], albumin (10 g/L decrease, RH = 2.05, P = 0.007), diabetes (RH = 3.42, P = 0.015) and peripheral vascular disease (RH = 2.19, P = 0.02) but not dialysis modality (RH = 1.63, P = 0.13). High and low mean blood pressure (BP) values at the start of dialysis were associated with the highest mortality.
Among the home dialysis patients, most of whom did not require antihypertensive drugs, hypertension was a risk factor for survival and patients with mid-range BP values survived the longest.
既往关于透析患者高血压风险的研究结果相互矛盾。本研究旨在调查在糖尿病和抗高血压药物使用率较低的家庭透析人群中,血压(BP)是否为生存的独立危险因素。
回顾性分析了1985年1月1日至1994年12月31日期间开始家庭血液透析(HD;n = 124)或家庭持续性非卧床腹膜透析(CAPD;n = 44)的168例连续患者(94例男性,88%为白种人)的结局,患者年龄48岁(标准差16)。透析期间仅4.7%的患者服用抗高血压药物。对患者随访至1998年12月31日,主要结局为全因死亡率。删失事件为移植、转至另一中心和治疗方式改变。使用Cox比例风险模型及基线预测因素。
71例患者死亡,总体生存中位数为4.2年(HD为5.6年,CAPD为2.2年,P < 0.0001)。透析开始时的平均血压自身可预测生存(P = 0.0009),在联合Cox模型中也可预测生存(P = 0.047)。联合模型中的其他显著预测因素为年龄[增加10岁,相对风险(RH)= 1.55,P = 0.0008]、白蛋白(降低10 g/L,RH = 2.05,P = 0.007)、糖尿病(RH = 3.42,P = 0.015)和外周血管疾病(RH = 2.19,P = 0.02),但不包括透析方式(RH = 1.63,P = 0.13)。透析开始时平均血压的高值和低值与最高死亡率相关。
在大多数不需要抗高血压药物的家庭透析患者中,高血压是生存的危险因素,血压值处于中等范围的患者生存时间最长。